Abstract P5-03-11: Germline and Somatic Variants in Patients with Inflammatory Breast Cancer (IBC) Detected Using Cell-Free DNA
Jennifer S. Winn,Zachary Hasse,Jianming Pei,Michael Slifker,Sebastian M. Arisi-Fernandez,Jacqueline N. Talarchek,Elias Obeid,Karthik Devarajan,Hong Wu,Yulan Gong,Massimo Cristofanilli,R.Katherine Alpaugh,Sandra Viviana Fernandez
DOI: https://doi.org/10.1158/1538-7445.sabcs19-p5-03-11
IF: 11.2
2020-01-01
Cancer Research
Abstract:Abstract In order to better understand the etiology of inflammatory breast cancer (IBC), we performed a retrospective study to evaluate genomic alterations in 32 IBC patients using circulating DNA from blood. In 20 patients, mutation analyses were also conducted on tumor tissue or tumor cells from pleural effusions; in 15 of these patients, blood and tissue or pleural effusions were collected at the same time. Next generation sequencing (NGS) and a panel of 93 breast cancer related genes (Qiagen) were used for these studies. We found that of the 32 total patients, 11 (34.4%) carried at least one putative pathogenic germline variant, and another 8 patients (25%) carried at least one likely pathogenic germline variant. Ten patients (31.3%) carried only germline variants of uncertain significance and in 3 patients (9.4%) germline variants were not detected. Putative germline pathogenic variants were observed in the BRCA2 (2/32), TP53 (2/32), BRCA1 (1/32), PALB2 (1/32), CHEK2 (1/32), ATM (1/32), PMS1 (1/32), MUTYH (1/32), and MSH2 (1/32) genes. In addition, putative germline likely pathogenic variants were observed in the BARD1 (10/32), RB1 (2/32), APC (1/32), FANCC (1/32), AR (1/32), RAD51C (1/32), RAD51D (1/32) and CASP8 (1/32) genes. Most of the patients in our study had a family history of cancer and seventeen of the patients (53.1%) had family history of breast cancer in particular. Of those patients, 7 had a family history of breast cancer at a young age (<45 years old). Other cancer in their families included prostate (28.1%), colon (28.1%) and skin cancer (12.5%). Somatic variants, pathogenic or likely pathogenic, were detected in: TP53, PTEN, MRE11, PMS2, RB1, AR, KMT2C, PIK3CA and BRCA1. These results suggest a high incidence of germline variants in patients with IBC that could be associated with an increased risk of developing the disease. This data, if validated in a larger cohort, would demonstrate the power that genomic analysis has to identify women at high-risk of developing IBC and who would benefit from early screening. Citation Format: Jennifer S. Winn, Zachary Hasse, Jianming Pei, Michael Slifker, Sebastian M. Arisi-Fernandez, Jacqueline N. Talarchek, Elias Obeid, Karthik Devarajan, Hong Wu, Yulan Gong, Massimo Cristofanilli, R.Katherine Alpaugh, Sandra Viviana Fernandez. Germline and somatic variants in patients with inflammatory breast cancer (IBC) detected using cell-free DNA [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P5-03-11.